Zika Virus Purifi ed Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study Z001
Fecha
2016Autor
Stephenson, Kathryn
Hale, Andrew
Ansel, Jessica
et al.
Metadatos
Mostrar el registro completo del ítemResumen
This is a phase 1 trial of one or more administrations of Zika Virus Purified Inactivated Vaccine (ZPIV). The trial will be conducted under a placebo controlled, double-blind, randomized allocation of study product. There are four groups in the study. Each group is testing a different vaccine schedule.